McKinsey Apologizes For Helping Purdue ‘Turbocharge’ Opioid Sales Too little too late – December 9, 2020 - In one internal email sent in July 2018, a McKinsey executive appears to acknowledge the growing legal risk faced by Purdue Pharma over its opioid business. “It prob... Read More...Big PharmaBooks, Memoirs, Films, and MediaDec 15 2020Drug Abuse and Addictionopioid crisisopioidsOverdosePurdue Pharma